Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide/semaglutide) in overweight or obese patients with type 2 diabetes.

Terpenes from the Cannabis sativa plant may be a viable medication for fibromyalgia and post-surgical pain relief, according to University of Arizona Health Sciences research published in ...

Since the proposed dual consolidated loss (DCL) and disregarded payment loss (DPL) rules were released in August 2024, taxpayers have been ...

Semaglutide shows promise in reducing alcohol cravings and consumption. Could it be a future treatment for AUD?

Whether it’s Ozempic, Pilates, or sheer will, celebrity transformations take all shapes and sizes - so what's the hassle all ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

Transformational drugs rarely emerge from a targeted, application-driven approach. Rather, they arise from deep scientific inquiry over many years, an approach that only robust, early-stage funding ...

After screening 20,000 protein-encoding genes in the human body, Stanford researchers have identified a naturally occurring ...

A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide—also known as ...

Novo Nordisk (NVO) plans to study how its GLP-1 drugs marketed as Wegovy and Ozempic for obesity and diabetes can help tackle ...